To investigate whether circSLC38A1 expression levels was regulated by epigenetic mechanisms, we treated BC cells with a DNA methyltransferase inhibitor 5-aza-dc, and HDAC inhibitors, SAHA and NAB, respectively. Here, HDAC9 is linked to breast cancer.